Anbio Biotechnology Net Income Loss

Quick Answer

Anbio Biotechnology reported Net Income Loss of $2.37 million for the year ending 2024.

  • Anbio Biotechnology showed an increase of +5.3% in Net Income Loss from 2023 to 2024.
  • This data is from Anbio Biotechnology's annual report (Form 10-K), filed with the SEC on April 28, 2025.
  • XBRL data for this metric is available from 2022 to 2024 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 3 years of available data (2022 to 2024), Anbio Biotechnology's Net Income Loss has declined by 76.3%.
  • Historical annual values: Fiscal year 2024: $2.37 million | Fiscal year 2023: $2.25 million | Fiscal year 2022: $10.01 million.
  • Data sourced from SEC EDGAR public filings as of June 22, 2026.

Last verified: